,,ii #aai? ,,congress #a/ ,session ,s4 #bccb ,,9 ,,! ,,s5ate ,,( ,,! ,,unit$ ,,/ates ,july #ag1 #bjbe ,ms4 ,hassan 7= h]self & ,mr4 ,cornyn7 introduc$ ! foll[+ bill2 :i* 0 read twice & ref]r$ to ! ,committee on ,heal?1 ,education1 ,labor1 & ,p5sions ,a ,,bill ,to require rese>* ) respect to f5tanyl & xylaz9e te/ /rips1 to au?orize ! use ( grant funds = su* te/ /rips1 & = o!r purposes4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,advanc+ ,lifesav+ ,ef=ts ) ,rapid ,te/ /rips = ,communities ,act or ! ,,al]t ,communities ,act4 #b4 ,grant program f ,/ate & ,tribal response to opioid use disord]s ,! activities c>ri$ out pursuant to section #ajjc7;b77#d77;,a7 ( ! #ba/ ,c5tury ,cures ,act 7#db ,u4,s4,c4 #bij;ee-#c note7 may include facilitat+ access to products us$ to prev5t ov]dose dea?s by detect+ ! pres5ce ( "o or m sub/ances1 su* z f5tanyl & xylaz9e te/ /rips1 to ! ext5t ! pur*ase & possession ( su* products is consi/5t ) ,f$]al & ,/ate law4 #c4 ,fir/ respond] tra9+ ,section #edf7;c7 ( ! ,public ,heal? ,s]vice ,act 7#db ,u4,s4,c4 #bij;ee-#a7;c77 is am5d$-- 7#a7 9 p>agraph 7#c71 by /rik+ 2 & & ins]t+ a semicolon2 7#b7 9 p>agraph 7#d71 by /rik+ ! p]iod & ins]t+ 2 &2 & 7#c7 by add+ at ! end ! foll[+3 7#e7 tra9 & provide res\rces = fir/ respond]s & memb]s ( o!r relevant community sectors on c>ry+ & facilitat+ access to f5tanyl or xylaz9e te/ /rips4 4 #d4 ,rese>* & m>ket+ frameworks = te/ /rip te*nology ,! ,secret>y ( ,heal? & ,human ,s]vices1 9 consultation ) ! ,director ( ! ,national ,in/itutes ( ,heal?1 ! ,director ( ! ,(fice ( ,national ,drug ,control ,policy1 ! ,commission] ( ,food & ,drugs1 & ! ,adm9i/rator ( ! ,drug ,en=cem5t ,adm9i/ration1 %all develop & make publicly available rese>* & m>ket+ frameworks = develop+1 improv+1 & evaluat+ te/ /rip te*nology = detect+ f5tanyl & o!r dang]\s sub/ances4 ,su* frameworks %all-- 7#a7 include /&>ds & guidance = manufactur]s seek+ to develop & te/ new te/ /rip te*nology2 7#b7 emphasize br++ new te/ /rip te*nology int5d$ = te/+ human specim5s 9 cl9ical sett+s to support on-site cl9ical decision-mak+2 & 7#c7 include guidance on available au?orization pa?ways = te/ /rips describ$ 9 p>agraphs 7#a7 & 7#b74 #e4 ,/udy on f5tanyl te/ /rip int]v5tions ,! ,secret>y ( ,heal? & ,human ,s]vices %all-- 7#a7 conduct a /udy on ! impact ( ! availability1 accessibility1 & usage ( drug *eck+ supplies1 includ+ te/ /rips1 on frequ5cy ( ov]dose1 ov]dose dea?s1 & engagem5t 9 sub/ance use disord] treatm5t2 & 7#b7 n lat] ?an #b ye>s aft] ! date ( enactm5t ( ?is ,act1 submit to ,congress a report on ! /udy conduct$ "u p>agraph 7#a74